Publication

Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.

Temporelli, Pier Luigi
Arbelo, Elena
Laroche, Cécile
Blomström-Lundqvist, Carina
Boriani, Giuseppe
Nakou, Eleni
Maggioni, Aldo P
Tavazzi, Luigi
Abstract
Of the 3582 AF patients in the Registry, 537 (14.9%) had HF. Diabetes, hypertension, hypercholesterolemia, CHA2DS2-VASc score ≥ 2, structural heart disease and persistent AF were more common in HF than non-HF patients (all p < 0.001). However the in-hospital complications were less frequent in HF patients (5.0% vs. 8.2% p = 0.01). Both in-hospital and 1-year outcomes, including 1-year AF recurrence (15.4%) and repeat ablations (9.5%), were similar in both groups. We subdivided HF patients according to their left ventricular ejection fraction (EF) at baseline into reduced (HFrEF, <40%), mid-range (HFmEF, 40-49%), or preserved EF (HFpEF, ≥ 50%). Most patients were HFpEF (n 375, 77%), 72 (15%) were HFmEF and 8% HFrEF. The most frequent underlying conditions in HFpEF were hypertension and ischemic heart disease, while those most common in HFmEF and HFrEF were valvular and dilated cardiomyopathy.
MIDER Authors
Affiliations
Istituti Clinici Scientifici Maugeri; Universitat de Barcelona; European Society of Cardiology; Sandwell and West Birmingham NHS Trust
Citations
Altmetric:
Date
2021-11-12
Type
Article
Other
Citation
Temporelli, P. L., Arbelo, E., Laroche, C., Blomström-Lundqvist, C., Kirchhof, P., Lip, G. Y. H., Boriani, G., Nakou, E., Maggioni, A. P., Tavazzi, L., & ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term Registry Investigators (2022). Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry. International journal of cardiology, 346, 19–26.
Publisher
Publisher’s URL
Publisher’s statement
Note / Copyright